Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Common Equity (2016 - 2026)

Cannabis Suisse has reported Common Equity over the past 11 years, most recently at -$1.7 million for Q1 2026.

  • Quarterly Common Equity rose 5.83% to -$1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.7 million through Feb 2026, up 5.83% year-over-year, with the annual reading at -$1.8 million for FY2025, 33.89% down from the prior year.
  • Common Equity was -$1.7 million for Q1 2026 at Cannabis Suisse, up from -$1.8 million in the prior quarter.
  • Over five years, Common Equity peaked at -$196079.0 in Q3 2022 and troughed at -$1.9 million in Q3 2024.
  • The 5-year median for Common Equity is -$476975.0 (2024), against an average of -$995180.0.
  • Year-over-year, Common Equity grew 22.99% in 2022 and then crashed 389.56% in 2024.
  • A 5-year view of Common Equity shows it stood at -$226129.0 in 2022, then tumbled by 80.87% to -$409001.0 in 2023, then plummeted by 358.64% to -$1.9 million in 2024, then rose by 5.87% to -$1.8 million in 2025, then increased by 1.52% to -$1.7 million in 2026.
  • Per Business Quant, the three most recent readings for CSUI's Common Equity are -$1.7 million (Q1 2026), -$1.8 million (Q4 2025), and -$1.8 million (Q3 2025).